Amendment 1 to Consulting Agreements Between Calypte Biomedical Corporation and Denise Lescasse-Laurent
Exhibit 4.1(i)
Amendment 1 to Consulting Agreements
Between Calypte Biomedical Corporation and Xxxxxx Xxxxxxxx-Xxxxxxx
This Agreement amends and modifies the Consulting Agreements between Calypte Biomedical Corporation (“Calypte” or the “Company”) and SARL MAJESTIC/Xxxxxx Xxxxxxxx-Xxxxxxx (“Consultant”) and is effective as of March 25, 2003.
1. | The Company acknowledges that as of March 25, 2003 it owes Consultant $19,772.42 for services rendered, payable in cash. It will now convert these payments to stock issuable to Consultant based on a value of approximately $0.025 per share for a total of 791,000 shares. |
2. | In consideration for this modification, the Company agrees to register the shares with the upcoming S-8 filing during March 2003. If the filing occurs after March, Consultant has the option to accept only cash. |
3. | All other terms and conditions of the 2002 Consultant Agreements remain unchanged. |
Consultant: |
Calypte Biomedical Corporation | |||||||
/s/ Xxxxxx Xxxxxxxx-Xxxxxxx |
By: |
/s/ Xxxxxxx X. Xxxxxxxxxx | ||||||
Xxxxxx Xxxxxxxx-Xxxxxxx |
Xxxxxxx X. Xxxxxxxxxx Executive Vice President, CFO |
26